Evidence and regulatory AI tools support the creation, review, and maintenance of documentation needed for clinical, regulatory, and market access decisions. These solutions typically help teams search and synthesise scientific and clinical evidence, structure regulatory and HTA narratives, and keep complex documents aligned with evolving data and guidelines. Key evaluation angles include control over source evidence and traceability, robustness of audit trails and versioning, fit with existing medical writing and regulatory workflows, and the extent to which they reduce manual burden without weakening scientific or compliance standards.
Browse the AI tools below to identify the Evidence & Regulatory solutions that best match your data, workflow, and governance requirements.
This category page is for informational purposes only and does not constitute regulatory, clinical, or investment advice; organisations should conduct their own technical, legal, and governance due diligence before selecting any AI solutions in healthcare.
Companies providing AI‑driven tools for scientific literature review in early drug discovery typically offer platforms that automate search, screening, tagging, and evidence synthesis across large biomedical databases, while preserving traceability of sources and review decisions. When comparing options, R&D leaders should assess coverage of life‑sciences data sources, transparency of inclusion/exclusion logic, and how easily outputs can feed into target identification, hypothesis generation, and downstream pipeline tools.
AI Tool Fit Summary:
MadeAi: Clearly relevant, as it provides an AI‑powered literature review platform and services for life‑sciences evidence synthesis, using GenAI to support protocol‑to‑report workflows and continuous literature surveillance that can underpin early drug discovery research questions.
